Effect of cardiovascular drugs on mortality in atrial fibrillation and chronic heart failure

References

• Forslund T, Wettermark B, Wandell P, von Euler M, Hasselstrom J, Hjemdahl P. Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system. Int J Cardiol. 2013;170:208–14.
   PubMed Web of Science ®Google Scholar
• Friberg L, Bergfeldt L. Atrial fibrillation prevalence revisited. J Intern Med. 2013;274:461–8.
   PubMedGoogle Scholar
• Seiler J, Stevenson WG. Atrial fibrillation in congestive heart failure. Cardiol Rev. 2010;18:38–50.
   PubMed Web of Science ®Google Scholar
• Humphries KH, Kerr CR, Connolly SJ, Klein G, Boone JA, Green M, et al. New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation. 2001; 103:2365–70.
   PubMed Web of Science ®Google Scholar
• Michelena HI, Powell BD, Brady PA, Friedman PA, Ezekowitz MD. Gender in atrial fibrillation: Ten years later. Gend Med. 2010;7:206–17.
   PubMed Web of Science ®Google Scholar
• Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67.
   PubMed Web of Science ®Google Scholar
• Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2007:CD006186.
   PubMed Web of Science ®Google Scholar
• Jang SJ, Kim MS, Park HJ, Han S, Kang DH, Song JK, et al. Impact of heart failure with normal ejection fraction on the occurrence of ischaemic stroke in patients with atrial fibrillation. Heart. 2013;99:17–21.
   PubMed Web of Science ®Google Scholar
• Bottai M, Zhang J. Laplace regression with censored data. Biom J. 2010;52:487–503.
   PubMed Web of Science ®Google Scholar
• Friberg L, Hammar N, Ringh M, Pettersson H, Rosenqvist M. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J. 2006;27:1954–64.
   PubMed Web of Science ®Google Scholar
• Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006;8:651–745.
   PubMed Web of Science ®Google Scholar
• Senn S, Graf E, Caputo A. Stratification for the propensity score compared with linear regression techniques to assess the effect of treatment or exposure. Stat Med. 2007;26: 5529–44.
   PubMed Web of Science ®Google Scholar
• Baldasseroni S, Orso F, Fabbri G, De Bernardi A, Cirrincione V, Gonzini L, et al. Age-dependent prognostic significance of atrial fibrillation in outpatients with chronic heart failure: data from the Italian Network on Congestive Heart Failure Registry. Cardiology. 2010;116:79–88.
   PubMed Web of Science ®Google Scholar
• Al Suwaidi J, Asaad N, Al-Qahtani A, El-Menyar A, Al-Mulla AW, Singh R, Albinali HA. Effect of age on outcome on patients hospitalized with heart failure: from a 20-year registry in a middle-eastern country (1991–2010). Congest Heart Fail. 2012;18:320–6.
   PubMedGoogle Scholar
• Fumagalli S, Tarantini F, Guarducci L, Pozzi C, Pepe G, Boncinelli L, et al. Atrial fibrillation is a possible marker of frailty in hospitalized patients: results of the GIFA Study. Aging Clin Exp Res. 2010;22:129–33.
   PubMed Web of Science ®Google Scholar
• Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet. 2007;370:493–503.
   PubMed Web of Science ®Google Scholar
• Carlsson AC, Wandell P, Sundquist K, Johansson SE, Sundquist J. Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors’ adherence to warfarin therapy recommendations: a Swedish study of prescribed drugs in primary care in 2002 and 2007. Eur J Clin Pharmacol. 2013;69:245–53.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–847.
   PubMed Web of Science ®Google Scholar
• Costanzo P, Perrone-Filardi P, Petretta M, Marciano C, Vassallo E, Gargiulo P, et al. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. J Hypertens. 2009;27:1136–51.
   PubMed Web of Science ®Google Scholar
• Shibata MC, Leon H, Chatterley T, Dorgan M, Vandermeer B. Do calcium channel blockers increase the diagnosis of heart failure in patients with hypertension? Am J Cardiol. 2010;106:228–35.
   PubMed Web of Science ®Google Scholar
• Aziz F, Tk LA, Enweluzo C, Dutta S, Zaeem M. Diastolic heart failure: a concise review. J Clin Med Res. 2013;5: 327–34.
   PubMedGoogle Scholar
• Gastelurrutia P, Lupon J, de Antonio M, Urrutia A, Diez C, Coll R, et al. Statins in heart failure: the paradox between large randomized clinical trials and real life. Mayo Clin Proc. 2012;87:555–60.
   PubMed Web of Science ®Google Scholar
• Komajda M, Hanon O, Hochadel M, Lopez-Sendon JL, Follath F, Ponikowski P, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Heart J. 2009;30:478–86.
   PubMed Web of Science ®Google Scholar
• Goette A. Upstream therapy for atrial fibrillation in heart failure. Heart Fail Clin. 2013;9:417–25.
   PubMed Web of Science ®Google Scholar
• Delgado-Rodriguez M, Llorca J. Bias. J Epidemiol Community Health. 2004;58:635–41.
   PubMed Web of Science ®Google Scholar
• Dahabreh IJ, Sheldrick RC, Paulus JK, Chung M, Varvarigou V, Jafri H, et al. Do observational studies using propensity score methods agree with randomized trials? A systematic comparison of studies on acute coronary syndromes. Eur Heart J. 2012;33:1893–901.
   PubMed Web of Science ®Google Scholar